$2.86 Billion is the total value of ALTRINSIC GLOBAL ADVISORS LLC's 140 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CTMX | Exit | Cytomx Therapeutics Inc. | $0 | – | -120,000 | -100.0% | -0.02% | – |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -140,000 | -100.0% | -0.02% | – |
| DCTH | Exit | Delcath Systems Inc. | $0 | – | -90,000 | -100.0% | -0.02% | – |
| AGTC | Exit | Applied Genetic Technologies Corp. | $0 | – | -376,900 | -100.0% | -0.02% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -70,000 | -100.0% | -0.04% | – |
| KURA | Exit | Kura Oncology Inc. | $0 | – | -110,000 | -100.0% | -0.05% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.05% | – |
| FATE | Exit | Fate Therapeutics Inc. | $0 | – | -27,000 | -100.0% | -0.05% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -216,500 | -100.0% | -0.05% | – |
| KZR | Exit | Kezar Life Sciences Inc | $0 | – | -100,000 | -100.0% | -0.05% | – |
| AXGN | Exit | Axogen Inc | $0 | – | -180,000 | -100.0% | -0.05% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -270,000 | -100.0% | -0.06% | – |
| NVST | Exit | Envista Holdings Corp | $0 | – | -50,000 | -100.0% | -0.07% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -442,452 | -100.0% | -0.07% | – |
| PRQR | Exit | PROQR THRAPEUTICS N V | $0 | – | -321,360 | -100.0% | -0.08% | – |
| JAZZ | Exit | Jazz Pharmaceutical plc | $0 | – | -21,000 | -100.0% | -0.08% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -168,800 | -100.0% | -0.09% | – |
| LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -110,000 | -100.0% | -0.10% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -45,000 | -100.0% | -0.10% | – |
| MORF | Exit | MORPHIC HLDG INC | $0 | – | -68,485 | -100.0% | -0.10% | – |
| ITCI | Exit | Intra-Cellular Therapies Inc. | $0 | – | -80,000 | -100.0% | -0.13% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -10,100 | -100.0% | -0.15% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -170,000 | -100.0% | -0.17% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -23,300 | -100.0% | -0.17% | – |
| SPNE | Exit | SEASPINE HLDGS CORP | $0 | – | -552,274 | -100.0% | -0.24% | – |
| EXC | Exit | EXELON CORP | $0 | – | -186,359 | -100.0% | -0.34% | – |
| KR | Exit | KROGER CO | $0 | – | -320,324 | -100.0% | -0.46% | – |
| HTA | Exit | Healthcare Trust of America- CL Acl a new | $0 | – | -528,617 | -100.0% | -0.56% | – |
| BKNG | Exit | BOOKING HOLDINGS INC | $0 | – | -34,753 | -100.0% | -2.66% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KINROSS GOLD CORP | 42 | Q3 2023 | 5.5% |
| BP PLC | 42 | Q3 2023 | 6.3% |
| COMCAST CORP NEW | 42 | Q3 2023 | 3.0% |
| PUBLIC SVC ENTERPRISE GRP IN | 42 | Q3 2023 | 2.7% |
| CISCO SYS INC | 42 | Q3 2023 | 2.4% |
| ORACLE CORP | 40 | Q1 2023 | 2.1% |
| VODAFONE GROUP PLC NEW | 39 | Q3 2023 | 7.5% |
| INTERCONTINENTAL EXCHANGE INC. | 37 | Q3 2023 | 4.5% |
| PEPSICO INC | 37 | Q2 2022 | 3.0% |
| EOG RES INC | 36 | Q3 2023 | 1.5% |
View ALTRINSIC GLOBAL ADVISORS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Diversicare Healthcare Services, Inc.Sold out | February 10, 2022 | 0 | 0.0% |
| AAC Holdings, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| trivago N.V.Sold out | February 13, 2019 | 0 | 0.0% |
| TearLab CorpSold out | February 14, 2018 | 0 | 0.0% |
| FOSTER WHEELER AG | February 13, 2014 | 1,488,236 | 1.5% |
| COOPER COMPANIES INC | February 08, 2010 | 71,500 | 0.1% |
| ADVOCAT INC | January 14, 2010 | 443,952 | 8.0% |
View ALTRINSIC GLOBAL ADVISORS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-10 |
View ALTRINSIC GLOBAL ADVISORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.